arteriosclerotic cardiovascular disease
Conditions
Interventions
Case series:Huoxin pill
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 30-75 years old; 2. Patients with angina pectoris symptoms within 12 months after PCI; 3. TCM syndrome differentiation is the syndrome of qi stagnation and blood stasis; 4. The patient signs an informed consent form, has good compliance, and cooperates with follow-up visits and re-examinations.
Exclusion criteria
Exclusion criteria: 1. Diagnosed as STEMI, or diagnosed as NSTEMI who is at high risk by Grace score; 2. Patients with congenital heart disease, severe pulmonary hypertension, malignant tumors, severe COPD; 3. Valvular disease (LVEF1.5 times the upper limit of normal value, Cr>1.2 times the upper limit of normal value (refer to the laboratory test of the research center for normal values Scope); Other clinically significant laboratory tests are abnormal and the investigator determines that it is not suitable to be included in the group; 5. People with allergies or allergic to the experimental drug Huoxin Pills, excipients or similar ingredients; 6. Suspected or true history of alcohol or drug abuse; 7. Pregnant or breastfeeding women or those who have planned pregnancy in the near future and are unwilling to use contraceptive measures; 8. Patients who have participated in other clinical trials within 1 month before enrollment; 9. The investigator believes that it is not suitable for patients to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nitroglycerin reduction rate; | — |
Countries
China
Contacts
Public ContactFan Min
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM
Outcome results
None listed